Statements (55)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:sneaker
|
gptkbp:bfsLayer |
7
|
gptkbp:bfsParent |
gptkb:Vyzulta
gptkb:latanoprost |
gptkbp:affects |
optic nerve
|
gptkbp:can_lead_to |
blindness
|
gptkbp:caused_by |
vision loss
irreversible blindness |
gptkbp:focuses_on |
patient education
public health initiatives clinical research |
https://www.w3.org/2000/01/rdf-schema#label |
open-angle glaucoma
|
gptkbp:is_associated_with |
inflammation
family history visual impairment retinal nerve fiber layer thinning trabecular meshwork dysfunction |
gptkbp:is_characterized_by |
increased intraocular pressure
|
gptkbp:is_considered_as |
early stages
|
gptkbp:is_influenced_by |
gptkb:Company
ethnicity high blood pressure myopia |
gptkbp:is_monitored_by |
regular eye exams
|
gptkbp:is_often_depicted_as |
angle-closure glaucoma
|
gptkbp:is_often_used_in |
older adults
|
gptkbp:is_studied_in |
ophthalmology
|
gptkbp:managed_by |
gptkb:stadium
stress reduction lifestyle changes dietary modifications |
gptkbp:recognizes |
visual field tests
optical coherence tomography tonometry |
gptkbp:requires |
lifetime management
|
gptkbp:scientific_classification |
gptkb:psychologist
eye diseases primary open-angle glaucoma secondary open-angle glaucoma |
gptkbp:social_responsibility |
eye examination
|
gptkbp:subject |
gptkb:municipality
awareness campaigns treatment protocols screening recommendations |
gptkbp:symptoms |
peripheral vision loss
tunnel vision |
gptkbp:treatment |
gptkb:hospital
medications laser therapy beta-blockers prostaglandin analogs carbonic anhydrase inhibitors Rho kinase inhibitors alpha agonists |
gptkbp:type_of |
chronic glaucoma
|